atropine has been researched along with Parkinson Disease in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (76.32) | 18.7374 |
| 1990's | 7 (18.42) | 18.2507 |
| 2000's | 1 (2.63) | 29.6817 |
| 2010's | 1 (2.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rowson, J; Squires, N; Wills, A | 1 |
| BOOIJ, J | 1 |
| BIRKMAYER, W; MENTASTI, M | 1 |
| PEPEU, G | 1 |
| Pasha, MK; Rajput, AH; Sharma, RK | 1 |
| Lauschke, HP; Thieme, F | 1 |
| Romo, R; Velasco, F; Velasco, M | 1 |
| Caviglia, A; Cellitti, M; Di Bianco, V; Di Castro, A; Pavoncello, S | 1 |
| Düsing, R; Glänzer, K; Ko, Y; Schmitz, U; Seewald, S; Vetter, H | 1 |
| Drukarch, B; Steinbusch, HW; Stoof, JC; Van Muiswinkel, FL | 1 |
| Goerdt, S; Schröder, K | 1 |
| Bramble, MG; Cunliffe, J; Dellipiani, AW | 1 |
| Hassler, R; Wagner, A | 1 |
| Baumann, P | 1 |
| David, J; Grewal, RS; Kaul, CL | 1 |
| Bermanzohn, PC; Lipper, S | 1 |
| Algeri, S; Bonollo, L; Buniva, G; Cerletti, C; Curcio, M; Minazzi, M; Minoli, G; Morselli, PL | 1 |
| Carlsson, A; Carlsson, M; Svensson, A | 1 |
| Andersen, EB; Boesen, F; Hesse, B; Jørgensen, F | 1 |
| Durrieu, G; Lataste, X; Montastruc, JL; Rascol, A; Rascol, O; Senard, JM; Tran, MA | 1 |
| Inzelberg, R; Korczyn, AD; Shapira, T | 1 |
| Greenblatt, DJ; Shader, RI | 1 |
| Kondo, K; Matsumura, K; Okuda, Y; Takahashi, Y; Yamamoto, T | 1 |
| Klawans, HL | 1 |
| Boshes, B; Brumlik, J | 1 |
| Jurna, I; Nell, T; Schreyer, I | 1 |
| Eichhorn, A; Schmutzler, F | 1 |
| Shibasaki, H | 1 |
| Barkhatova, VP; Gotovtseva, EV; Ivanova-Smolenskaia, IA; Markova, ED; Tkachev, RA | 1 |
| Bateson, MC; Gibberd, FB; Wilson, RS | 1 |
| Morrison, AB; Webster, RA | 1 |
| Nakajima, T | 1 |
| Pálosi, E; Szporny, L | 1 |
| Oelszner, W; Wagner, U; Walther, H | 1 |
| Boman, K; Meurman, T | 1 |
| Clark, R; Grelak, RP; Stump, JM; Vernier, VG | 1 |
| Marshall, J; Schnieden, H | 1 |
9 review(s) available for atropine and Parkinson Disease
| Article | Year |
|---|---|
The management of drooling in adults with neurological conditions.
Topics: Administration, Cutaneous; Adult; Amitriptyline; Atropine; Behavior Therapy; Botulinum Toxins, Type A; Cerebral Palsy; Child; Cholinergic Antagonists; Cooperative Behavior; Deglutition Disorders; Glycopyrrolate; Humans; Interdisciplinary Communication; Motor Neuron Disease; Nervous System Diseases; Parkinson Disease; Patient Care Team; Salivary Glands; Scopolamine; Sialorrhea | 2012 |
Locomotor activity and speed of movements in relation to monoamine-acting drugs.
Topics: Animals; Atropine; Basal Ganglia; Cats; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Harmaline; Humans; Hydroxydopamines; Methamphetamine; Motor Activity; Motor Neurons; Norepinephrine; Parkinson Disease; Rats; Reserpine; Substantia Nigra | 1975 |
[ECT: The apple of discord in modern psychiatry (author's transl)].
Topics: Aggression; Anxiety; Atropine; Biogenic Amines; Confusion; Cyclic AMP; Depression; Diazepam; Electroconvulsive Therapy; Female; Humans; Intracranial Pressure; Memory; Menstruation Disturbances; Norepinephrine; Obesity; Parkinson Disease; Premedication; Prolactin; Schizophrenia; Serotonin | 1979 |
Drug therapy. Anticholinergics.
Topics: Antidotes; Asthma; Atropine; Gastrointestinal Diseases; Heart Diseases; Histamine H1 Antagonists; Humans; Motion Sickness; Mydriatics; Parasympatholytics; Parkinson Disease; Poisoning; Pralidoxime Compounds; Preanesthetic Medication; Respiratory Tract Infections; Scopolamine; Vertigo | 1973 |
The pharmacology of parkinsonism (a review).
Topics: Acetylcholine; Animals; Atropa belladonna; Atropine; Central Nervous System; Chlorpromazine; Dextroamphetamine; Dihydroxyphenylalanine; Diphenhydramine; Dopa Decarboxylase; Dopamine; Drug Synergism; Epinephrine; Haloperidol; Histamine H1 Antagonists; Humans; Mice; Monoamine Oxidase; Norepinephrine; Parkinson Disease; Parkinson Disease, Secondary; Peripheral Nerves; Phytotherapy; Plants, Medicinal; Plants, Toxic; Reserpine; Trihexyphenidyl | 1968 |
Recent advances in the treatment of parkinsonism.
Topics: Aged; Atropine; Attitude; Depression; Female; Humans; Male; Methods; Middle Aged; Muscles; Paranoid Disorders; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Psychotherapy; Scopolamine | 1969 |
[Antiparkinson agents. 50].
Topics: Atropine; Dihydroxyphenylalanine; Diphenhydramine; Histamine H1 Antagonists; Humans; Mephenesin; Monoamine Oxidase Inhibitors; Nialamide; Parasympatholytics; Parkinson Disease; Phenothiazines; Propranolol; Pyridoxine; Scopolamine | 1970 |
Parkinson's syndrome. Recent progress in the medical treatment and its pharmacological basis.
Topics: Amantadine; Atropine; Catecholamines; Dihydroxyphenylalanine; Histamine H1 Antagonists; Humans; Imipramine; Parkinson Disease; Tryptophan | 1971 |
[Biochemical aspect of Parkinson's disease].
Topics: Acetylcholine; Animals; Atropine; Basement Membrane; Brain; Carbachol; Catecholamines; Dihydroxyphenylalanine; Electrocoagulation; Humans; Manganese; Melanins; Neurophysiology; Parkinson Disease | 1968 |
1 trial(s) available for atropine and Parkinson Disease
| Article | Year |
|---|---|
Oesophageal transit in patients with autonomic dysfunction. The effect of treatment with fludrocortisone.
Topics: Adult; Aged; Atropine; Autonomic Nervous System Diseases; Diabetic Neuropathies; Esophagus; Female; Fludrocortisone; Gastrointestinal Transit; Humans; Hypotension, Orthostatic; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Time Factors | 1991 |
28 other study(ies) available for atropine and Parkinson Disease
| Article | Year |
|---|---|
[Synthetic drugs in therapy of parkinsonism].
Topics: Atropine; Humans; Parkinson Disease; Parkinsonian Disorders | 1953 |
[Features of medical therapy of Parkinson's syndrome].
Topics: Atropa belladonna; Atropine; Dihydroxyphenylalanine; Gastrointestinal Agents; Humans; Monoamine Oxidase Inhibitors; Muscarinic Antagonists; Parasympatholytics; Parkinson Disease | 1962 |
EFFECT OF 'TREMORINE' AND SOME ANTI-PARKINSON'S DISEASE DRUGS ON ACETYLCHOLINE IN THE RAT'S BRAIN.
Topics: Acetylcholine; Atropine; Brain; Heterocyclic Compounds; Parasympatholytics; Parkinson Disease; Pharmacology; Rats; Research; Tremorine | 1963 |
Increased myocardial N-myristoyltransferase activity in rotenone model of Parkinsonism.
Topics: Acyl Coenzyme A; Aminophylline; Animals; Atropine; Disease Models, Animal; Drug Combinations; Humans; Male; Nitroglycerin; Papaverine; Parkinson Disease; Phenobarbital; Rats; Rats, Inbred Lew; Rotenone | 2005 |
[Parkinson disease].
Topics: Atropine; Automobile Driving; Biogenic Amines; Diagnosis, Differential; Disability Evaluation; Extrapyramidal Tracts; Humans; Levodopa; Neurotransmitter Agents; Parkinson Disease; Physical Therapy Modalities; Substantia Nigra | 1981 |
Effect of carbachol and atropine perfusions in the mesencephalic tegmentum and caudate nucleus on experimental tremor in monkeys.
Topics: Animals; Atropine; Carbachol; Caudate Nucleus; Disease Models, Animal; Macaca mulatta; Parkinson Disease; Perfusion; Tegmentum Mesencephali | 1982 |
[Neurological aspects and modern trends in therapy of Parkinson's disease].
Topics: Atropine; Biperiden; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Procyclidine; Trihexyphenidyl | 1980 |
[Orthostatic hypotension].
Topics: Aged; Atropine; Diagnosis, Differential; Female; Humans; Hypotension, Orthostatic; Infusion Pumps; Parkinson Disease; Shy-Drager Syndrome; Urinary Incontinence | 1995 |
Dopamine D-2 autoreceptors regulating the release of dopamine from cultured rat fetal dopaminergic neurons do not desensitize upon sustained activation: implications for the combined pharmaco- and grafting therapy in parkinsonian patients.
Topics: Animals; Atropine; Brain Tissue Transplantation; Carbachol; Cells, Cultured; Dopamine; Dopamine Agents; Ergolines; Fetal Tissue Transplantation; Fetus; Mesencephalon; Neurons; Parkinson Disease; Potassium; Quinpirole; Rats; Receptors, Dopamine D2; Receptors, Muscarinic | 1994 |
[Multiple eccrine hidrocystomas in Parkinson disease].
Topics: Administration, Topical; Atropine; Eccrine Glands; Facial Neoplasms; Female; Hidrocystoma; Humans; Middle Aged; Parkinson Disease | 1997 |
Evidence for a change in neurotransmitter affecting oesophageal motility in Parkinson's disease.
Topics: Aged; Atropine; Bethanechol Compounds; Brain Stem; Deglutition Disorders; Esophagogastric Junction; Esophagus; Female; Humans; Male; Manometry; Middle Aged; Neurotransmitter Agents; Parkinson Disease; Peristalsis; Receptors, Cholinergic; Vagus Nerve | 1978 |
Effect of intracaudate drug injections on the striatal syndrome in reserpinized cats.
Topics: Animals; Apomorphine; Atropine; Cats; Caudate Nucleus; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Dopamine; Male; Neuromuscular Diseases; Parkinson Disease; Reserpine; Syndrome | 1977 |
Letter: Electroconvulsive therapy in patients with parkinsonism.
Topics: Amantadine; Atropine; Depression; Diphenhydramine; Electroconvulsive Therapy; Female; Humans; Levodopa; Methohexital; Middle Aged; Parkinson Disease; Succinylcholine; Suicide | 1975 |
Effect of anticholinergic drugs on gastro-intestinal absorption of L-dopa in rats and in man.
Topics: Administration, Oral; Adult; Aged; Animals; Atropine; Digestive System; Drug Interactions; Female; Humans; Injections, Intraperitoneal; Intestinal Absorption; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Rats; Time Factors; Trihexyphenidyl | 1976 |
Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice.
Topics: Adrenergic alpha-Agonists; Animals; Atropine; Biperiden; Clonidine; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Ketamine; Male; Methyldopa; Mice; Mice, Neurologic Mutants; Motor Activity; N-Methylaspartate; Parasympatholytics; Parkinson Disease; Piperazines | 1991 |
Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243).
Topics: Antiparkinson Agents; Atropine; Blood Pressure; Epinephrine; Female; Heart Rate; Humans; Indoles; Male; Middle Aged; Norepinephrine; Parkinson Disease; Phenanthridines; Posture; Reference Values | 1990 |
Effects of atropine on learning and memory functions in dementia.
Topics: Alzheimer Disease; Atropine; Dementia; Dementia, Multi-Infarct; Humans; Learning; Memory; Parkinson Disease | 1990 |
[Treatment of Parkinsonism with Tremarial (SJ-1977)].
Topics: Adolescent; Adult; Atropine; Female; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary; Phenothiazines; Piperidines; Schizophrenia; Xanthenes | 1967 |
Motor disturbance induced by tremorine and oxotremorine.
Topics: Acetylcholine; Amines; Animals; Atropine; Biperiden; Brain; Bridged-Ring Compounds; Chlorpromazine; Depression, Chemical; Dihydroxyphenylalanine; Electromyography; Ethanolamines; Motor Activity; Motor Neurons; Parasympatholytics; Parkinson Disease; Piperazines; Procaine; Propranolol; Pyrrolidines; Rats; Reflex; Spinal Nerves; Tremor; Tremorine; Vasodilator Agents | 1970 |
[Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
Topics: Adolescent; Adult; Atropine; Basal Ganglia Diseases; Chelating Agents; Chronic Disease; Dihydroxyphenylalanine; Female; Hepatolenticular Degeneration; Humans; Hyperkinesis; Male; Pantothenate Kinase-Associated Neurodegeneration; Parkinson Disease; Penicillamine; Phenothiazines; Pyridoxine; Sulfhydryl Compounds; Trifluoperazine; Tropanes | 1973 |
Salivary symptoms in Parkinson disease.
Topics: Adult; Aged; Atropine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease; Salivary Gland Diseases; Salivation | 1973 |
Drug-induced experimental Parkinsonism.
Topics: Animals; Atropine; Benztropine; Butyrophenones; Cats; Chlorpromazine; Dose-Response Relationship, Drug; Electromyography; Motor Neurons; Parkinson Disease; Parkinson Disease, Secondary; Phenothiazines; Rabbits; Rats; Reserpine; Tetanus; Time Factors; Tremorine; Trifluoperazine | 1973 |
Effect of gamma-hydroxybutyric acid on tremor induced oxotremorin.
Topics: Animals; Atropine; Brain Chemistry; Disease Models, Animal; Drug Antagonism; Drug Synergism; Female; Hydroxybutyrates; Locomotion; Male; Mice; Motor Activity; Oxotremorine; Parkinson Disease; Tremor | 1972 |
[Antimuscarinic action of parkinsonism drugs on peripheral structures and correlation with central efficacy or clinical dosage].
Topics: Animals; Atropine; Blood Pressure; Central Nervous System; Guinea Pigs; Heart; Heart Rate; Ileum; Mice; Mydriatics; Organ Culture Techniques; Parasympatholytics; Parkinson Disease; Peripheral Nerves; Rats; Scopolamine; Stomach | 1971 |
Investigations on the effect of some drugs on the Parkinsonian rigidity.
Topics: Adult; Atropine; Biperiden; Female; Humans; Injections, Intravenous; Male; Middle Aged; Muscle Contraction; Orphenadrine; Oscillometry; Parasympatholytics; Parkinson Disease; Procyclidine; Tropanes | 1970 |
Amantadine-dopamine interaction: possible mode of action in Parkinsonism.
Topics: Acetylcholine; Amantadine; Animals; Atropine; Dogs; Dopamine; Neurons; Parkinson Disease; Stimulation, Chemical; Vagotomy | 1970 |
Antiparkinsonism drugs.
Topics: Antidepressive Agents; Atropine; Diphenhydramine; Humans; Orphenadrine; Parasympatholytics; Parkinson Disease; Promethazine; Scopolamine; Trihexyphenidyl | 1965 |
Effect of adrenaline, noradrenaline, atropine, and nicotine on some types of human tremor.
Topics: Adult; Aged; Anxiety; Atropine; Cerebellar Diseases; Epinephrine; Female; Humans; Male; Middle Aged; Nicotine; Norepinephrine; Parkinson Disease; Tremor | 1966 |